FluroTech Ltd. (FLURF)
USD 0.0
(N/A%)
USD 0.0
(N/A%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 144.01 Thousand CAD | -76.39% |
| 2022 | 609.94 Thousand CAD | -81.45% |
| 2021 | 3.28 Million CAD | 265.74% |
| 2020 | 899.25 Thousand CAD | -80.06% |
| 2019 | 4.51 Million CAD | -0.08% |
| 2018 | 4.51 Million CAD | 9930.4% |
| 2017 | 45 Thousand CAD | 14.73% |
| 2016 | 39.22 Thousand CAD | -28.55% |
| 2015 | 54.89 Thousand CAD | 3.95% |
| 2014 | 52.81 Thousand CAD | -46.89% |
| 2013 | 99.44 Thousand CAD | 45.52% |
| 2012 | 68.33 Thousand CAD | -47.08% |
| 2011 | 129.13 Thousand CAD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 233.68 Thousand CAD | 607.03% |
| 2024 Q2 | 34.52 Thousand CAD | -85.22% |
| 2023 Q4 | 33.05 Thousand CAD | -23.52% |
| 2023 Q3 | 43.21 Thousand CAD | 34.86% |
| 2023 Q2 | 32.04 Thousand CAD | -10.24% |
| 2023 FY | 144.01 Thousand CAD | -76.39% |
| 2023 Q1 | 35.7 Thousand CAD | -55.43% |
| 2022 Q1 | 290.38 Thousand CAD | -47.54% |
| 2022 Q3 | 99.41 Thousand CAD | -29.02% |
| 2022 Q2 | 140.04 Thousand CAD | -51.77% |
| 2022 FY | 609.94 Thousand CAD | -81.45% |
| 2022 Q4 | 80.1 Thousand CAD | -19.42% |
| 2021 FY | 3.28 Million CAD | 265.74% |
| 2021 Q3 | 1.16 Million CAD | 17.38% |
| 2021 Q4 | 553.53 Thousand CAD | -52.42% |
| 2021 Q1 | 580.81 Thousand CAD | 172.98% |
| 2021 Q2 | 991.16 Thousand CAD | 70.65% |
| 2020 Q3 | 318.04 Thousand CAD | -42.81% |
| 2020 Q4 | -795.84 Thousand CAD | -350.23% |
| 2020 Q1 | 996.85 Thousand CAD | -26.65% |
| 2020 FY | 899.25 Thousand CAD | -80.06% |
| 2020 Q2 | 556.16 Thousand CAD | -44.21% |
| 2019 Q3 | 920.96 Thousand CAD | -32.29% |
| 2019 FY | 4.51 Million CAD | -0.08% |
| 2019 Q1 | 869.85 Thousand CAD | -33.79% |
| 2019 Q2 | 1.36 Million CAD | 56.38% |
| 2019 Q4 | 1.35 Million CAD | 47.57% |
| 2018 Q1 | 11.22 Thousand CAD | -18.91% |
| 2018 Q4 | 1.31 Million CAD | -13.72% |
| 2018 Q3 | 1.52 Million CAD | 61.25% |
| 2018 Q2 | 944.31 Thousand CAD | 8314.1% |
| 2018 FY | 4.51 Million CAD | 9930.4% |
| 2017 Q1 | 6758.00 CAD | -51.6% |
| 2017 FY | 45 Thousand CAD | 14.73% |
| 2017 Q4 | 13.84 Thousand CAD | 52.05% |
| 2017 Q3 | 9103.00 CAD | -40.5% |
| 2017 Q2 | 15.3 Thousand CAD | 126.4% |
| 2016 Q2 | 10.06 Thousand CAD | 22.77% |
| 2016 Q3 | 6997.00 CAD | -30.49% |
| 2016 Q4 | 13.96 Thousand CAD | 99.56% |
| 2016 FY | 39.22 Thousand CAD | -28.55% |
| 2016 Q1 | 8199.00 CAD | -59.06% |
| 2015 Q4 | 20.02 Thousand CAD | 139.9% |
| 2015 Q3 | 8349.00 CAD | 12.52% |
| 2015 Q2 | 7420.00 CAD | -61.15% |
| 2015 FY | 54.89 Thousand CAD | 3.95% |
| 2015 Q1 | 19.1 Thousand CAD | 99.31% |
| 2014 Q4 | 9583.00 CAD | -0.59% |
| 2014 Q1 | 14.27 Thousand CAD | -1.86% |
| 2014 FY | 52.81 Thousand CAD | -46.89% |
| 2014 Q2 | 19.31 Thousand CAD | 35.34% |
| 2014 Q3 | 9640.00 CAD | -50.09% |
| 2013 FY | 99.44 Thousand CAD | 45.52% |
| 2013 Q1 | 26.77 Thousand CAD | -40.28% |
| 2013 Q2 | 7160.00 CAD | -73.25% |
| 2013 Q3 | 50.96 Thousand CAD | 611.86% |
| 2013 Q4 | 14.54 Thousand CAD | -71.47% |
| 2012 Q4 | 44.82 Thousand CAD | 241.67% |
| 2012 Q1 | 5268.00 CAD | -94.1% |
| 2012 FY | 68.33 Thousand CAD | -47.08% |
| 2012 Q3 | 13.12 Thousand CAD | 156.2% |
| 2012 Q2 | 5121.00 CAD | -2.79% |
| 2011 Q4 | 89.29 Thousand CAD | 1534.86% |
| 2011 Q1 | 92.34 Thousand CAD | 0.0% |
| 2011 Q2 | 15.03 Thousand CAD | -83.72% |
| 2011 FY | 129.13 Thousand CAD | 0.0% |
| 2011 Q3 | 5462.00 CAD | -63.67% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| ADM Tronics Unlimited, Inc. | 1.69 Million USD | 91.507% |
| Avitar, Inc. | 3.56 Million USD | 95.966% |
| Capital Group Holdings, Inc. | 634.68 Thousand USD | 77.31% |
| CVR Medical Corp. | - USD | -Infinity% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| Manhattan Scientifics, Inc. | 703 Thousand USD | 79.515% |
| Össur hf. | 396.18 Million USD | 99.964% |
| Össur hf. | 396.18 Million USD | 99.964% |
| SS Innovations International, Inc. | 21.38 Million USD | 99.326% |
| VMS Rehab Systems, Inc. | 63.63 USD | -226225.633% |
| QHSLab, Inc. | 961.65 Thousand USD | 85.025% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| BrainsWay Ltd. | 28.01 Million USD | 99.486% |
| BioElectronics Corporation | 740.67 Thousand USD | 80.557% |
| Hamilton Thorne Ltd. | 33.57 Million USD | 99.571% |
| Theraclion SA | 7.43 Million USD | 98.064% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Positron Corporation | 1 Million USD | 85.703% |
| Stratec SE | 46.32 Million USD | 99.689% |
| AVITA Medical, Inc. | 80.77 Million USD | 99.822% |
| Nu-Med Plus, Inc. | 120.52 Thousand USD | -19.485% |
| Zecotek Photonics Inc. | 3.46 Million USD | 95.84% |
| Wellstar International, Inc. | 1.79 Million USD | 91.976% |
| EKF Diagnostics Holdings plc | 21.77 Million USD | 99.339% |
| Escalon Medical Corp. | 5.25 Million USD | 97.257% |
| Guided Therapeutics, Inc. | 3.49 Million USD | 95.877% |
| Aurora Spine Corporation | 8.65 Million USD | 98.337% |
| NewCardio, Inc. | 9.56 Million USD | 98.494% |
| Vivos Inc. | 2.78 Million USD | 94.833% |
| MicroPort Scientific Corporation | 1.04 Billion USD | 99.986% |
| Kelyniam Global, Inc. | 2.27 Million USD | 93.671% |
| REMSleep Holdings, Inc. | 1.01 Million USD | 85.81% |
| CYduct Diagnostics, Inc. | 435.5 Thousand USD | 66.932% |
| Nanomix Corporation | 8.36 Million USD | 98.279% |
| IR-Med Inc. | 4.89 Million USD | 97.057% |
| Wellness Center USA, Inc. | 1.29 Million USD | 88.876% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 3.11 Million USD | 95.37% |
| Lombard Medical, Inc. | 30.29 Million USD | 99.525% |
| ALR Technologies Inc. | 6.33 Million USD | 97.727% |
| Vycor Medical, Inc. | 1.27 Million USD | 88.709% |
| Heart Tronics, Inc. | 14.46 Million USD | 99.004% |
| Perimeter Medical Imaging AI, Inc. | 206.41 Thousand USD | 30.234% |
| SANUWAVE Health, Inc. | 14.15 Million USD | 98.982% |
| Ingen Technologies, Inc. | 1.88 Million USD | 92.349% |
| United American Healthcare Corporation | 59 Thousand USD | -144.086% |
| Odyssey Group International, Inc. | -14.26 Million USD | 101.01% |
| ECGI Holdings, Inc. | 407.48 Thousand USD | 64.659% |
| Polarean Imaging plc | 12.24 Million USD | 98.824% |
| Medical Supply International USA, Inc. | 1.32 Million USD | 89.094% |
| Urologix, Inc. | 10.09 Million USD | 98.573% |
| Rapid Therapeutic Science Laboratories, Inc. | 1.26 Million USD | 88.601% |
| Nexeon MedSystems Inc. | 5.94 Million USD | 97.579% |
| Qualis Innovations, Inc. | 230.24 Thousand USD | 37.452% |
| Smith & Nephew plc | 3.46 Billion USD | 99.996% |
| NIOX Group Plc | 22.27 Million USD | 99.354% |
| Fuse Medical, Inc. | 10.35 Million USD | 98.609% |
| Broncus Holding Corporation | 38.15 Million USD | 99.623% |
| Brain Scientific Inc. | 9.66 Million USD | 98.51% |
| Pressure BioSciences, Inc. | 10.3 Million USD | 98.602% |
| Health Logic Interactive Inc. | 60.69 Thousand USD | -137.258% |